Therapeutic effect of Nivolumab for advanced / recurrent temporal bone squamous cell carcinoma.
Auris Nasus Larynx
; 47(5): 864-869, 2020 Oct.
Article
in En
| MEDLINE
| ID: mdl-32446629
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Skull Neoplasms
/
Temporal Bone
/
Carcinoma, Squamous Cell
/
Antineoplastic Agents, Immunological
/
Nivolumab
Type of study:
Observational_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Auris Nasus Larynx
Year:
2020
Document type:
Article